MedTrace Logo

A Registered Cohort Study on Duchenne Muscular Dystrophy

NCT04012671 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2021-03-22

No results posted yet for this study

Summary

Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.

Conditions

Sponsors & Collaborators

  • Ning Wang, MD., PhD.

    lead OTHER

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2039-12-31
Completion
2049-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04012671 on ClinicalTrials.gov